Cases & Deals

Micreos teams up with L'Oréal for skin care products containing endolysins

Clients Micreos Human Health B.V.

Jones Day represented Micreos Human Health B.V. in its license out to L'Oréal of endolysin technology that targets harmful skin bacteria while preserving useful bacteria for L'Oréal's use worldwide in skin care products for cosmetic applications. Micreos sells such products under the GLADSKIN brand.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.